Mbe Wealth Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Mbe Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$25.16 - $41.38 $145,299 - $238,969	5,775 New	5,775 $205,000
Q2 2022 Jul 19, 2022	SELL	$27.79 - $50.61 $694 - $1,265	-25 Reduced 0.38%	6,500 $229,000
Q4 2021 Jan 19, 2022	BUY	$58.09 - $82.51 $13,360 - $18,977	230 Added 3.65%	6,525 $433,000
Q3 2021 Oct 25, 2021	BUY	$58.38 - $84.96 $367,502 - $534,823	6,295 New	6,295 $393,000
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $91,420 - $151,445	-3,500 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$20.56 - $63.12 $1,870 - $5,743	-91 Reduced 2.53%	3,500 $100,000
Q4 2019 Jan 30, 2020	BUY	$28.14 - $73.01 $101,050 - $262,178	3,591 New	3,591 $227,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Mbe Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Mbe Wealth Management, LLC with notifications on news.